You searched for Antibody candidate - Page 66 of 67

multiple sclerosis novartis roche ema approval

News and Trends 27 Apr 2021

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

…destroying the protective coating of nerve cells called myelin. In the case of Kesimpta, the antibody drug is designed to destroy harmful B cells as does Roche’s Ocrevus, except Kesimpta…

April 27, 2021 - 6 minutesmins - By Jonathan Smith

News and Trends 4 Aug 2022

Gilead Sciences set to acquire MiroBio for $405M

…cash, subject to customary adjustments. The acquisition will provide Gilead with MiroBio’s discovery platform and entire portfolio of immune inhibitory receptor agonists. MiroBio’s lead investigational antibody, MB272, is a selective…

August 4, 2022 - 2 minutesmins - By Jim Cornall

paris ermium therapeutics autoimmune disease

Startup Scout 18 Oct 2019

This Biotech Fights Autoimmune Disease with Rare Immune Cells

…specific than existing drugs. The UK biotech MiroBio was founded earlier this month to develop antibody treatments that block immune cells called T-cells from attacking healthy tissue. The Dutch company…

October 18, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 28 Oct 2016

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

…collaboration to evaluate its lead candidate NY-ESO SPEAR T-cell therapy in combination with MSD’s Keytruda (pembrolizumab). Adaptimmune will sponsor the trial aimed at multiple myeloma, a form of blood cancer…

October 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Apr 2023

InflaRx receives emergency use authorization for critically ill COVID-19 patients treatment

…and Drug Administration (FDA) for the treatment of COVID-19 in hospitalized adults. Vilobelimab is a first-in-class monoclonal anti-human complement factor C5a antibody that acts on the immune system and not…

April 5, 2023 - 4 minutesmins - By Jim Cornall

Interview 20 Nov 2018

Why Denmark Is a Strong Player in Europe’s Biotech Industry

…helix, the antibody invention, the CRISPR technology is European.” She also pointed out that getting a company through the early stages comes at a lower cost in Europe than in…

November 20, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Podcast 15 Dec 2023

Vaxxinity making vaccines to change the world

…Vaxxinity’s proprietary technology platform has enabled the innovation of novel synthetic peptide immunotherapy candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases. These include Alzheimer’s…

December 15, 2023 - 7 minutesmins - By Jim Cornall

Best in Biotech 5 Mar 2024

Fourteen biotech companies with market caps exceeding $100 billion

…clinical development programs, and Seagen Inc. for antibody-drug conjugates for cancer, among others. Vertex Pharmaceuticals – $112 billion The American biotech company reported a $9.9 billion revenue in the financial…

March 5, 2024 - 18 minutesmins - By Jules Adam

News and Trends 30 Mar 2017

Merck Outsources the Development of its Nanobody for Psoriasis

…Merck and the unbeaten nanobody biotech Ablynx, Merck recently cleared Phase Ib with its llama-inspired nanobody targeting the cytokines IL-17 A/F for the treatment of plaque psoriasis. The antibody is…

March 30, 2017 - 3 minutesmins - By Melanie De Almeida

Woman looking through a window and seeing biotechnology such as pills and vaccines. It indicates the biotech trends coming in the future

Best in Biotech 12 Jan 2023

The biggest biotech trends that will shape 2023

…its entire class.” “The fact that Roche’s own beta amyloid-directed antibody gantenerumab failed phase 3 trials adds more confusion and raises more questions than answers about the viability of this…

January 12, 2023 - 9 minutesmins - By Jonathan Smith

News and Trends 15 Mar 2018

Can MorphoSys’ Alzheimer’s Treatment Work Where Big Pharma has Failed?

Roche has positive clinical data in support of starting a Phase III trial in Alzheimer’s with an antibody initially developed by MorphoSys. However, the field is full of similar approaches…

March 15, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 4 Aug 2022

Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

…footprint in China. Both companies said they are committed to accelerating the development and commercialization of two Sanofi key clinical stage oncology assets: Phase III SAR408701 (tusamitamab ravtansine; anti-CEACAM5 antibody-drug…

August 4, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

Gilead Sciences set to acquire MiroBio for $405M

This Biotech Fights Autoimmune Disease with Rare Immune Cells

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

InflaRx receives emergency use authorization for critically ill COVID-19 patients treatment

Why Denmark Is a Strong Player in Europe’s Biotech Industry

Vaxxinity making vaccines to change the world

Fourteen biotech companies with market caps exceeding $100 billion

Merck Outsources the Development of its Nanobody for Psoriasis

The biggest biotech trends that will shape 2023

Can MorphoSys’ Alzheimer’s Treatment Work Where Big Pharma has Failed?

Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!